ConductScience.org, home

Paper · 11274381

Uncoupling fibroblast growth factor receptor 2 ligand binding specificity leads to Apert syndrome-like phenotypes.

Yu K and 1 other. Proc Natl Acad Sci U S A, 2001. Cited by 43 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Uncoupling fibroblast growth factor receptor 2 ligand binding specificity leads to Apert syndrome-like phenotypes. Papers, record 11274381. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11274381

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Uncoupling fibroblast growth factor receptor 2 ligand binding specificity leads to Apert syndrome-like phenotypes.
PubMed
Journal
Proc Natl Acad Sci U S A
PubMed
Year
2001
PubMed
Publication types
Comment, Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
43
iCite
Relative citation ratio, by iCite
0.79
iCite
Revised in PubMed
2018-11-13
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yu KK
2Ornitz DMD M

Source PubMed

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AcrocephalosyndactyliaMajor topic
Receptor Protein-Tyrosine KinasesMajor topic
Receptors, Fibroblast Growth FactorMajor topic
Animals
Disease Models, Animal
Fibroblast Growth Factors
Humans
Ligands
Mice
Mutation
Phenotype
Receptor, Fibroblast Growth Factor, Type 2
Signal Transduction

Source PubMed

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
HD30652NICHD NIH HHSUnited StatesPubMed

Source PubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment on11,274,405A splicing switch and gain-of-function mutation in FgfR2-IIIc hemizygotes causes Apert/Pfeiffer-syndrome-like phenotypes.https://conductscience.org/library/papers/11274405

Source PubMed

References33

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110,631,169An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis.Development2000https://conductscience.org/library/papers/10631169PubMed
27,719,344Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome.Nat Genet1995https://conductscience.org/library/papers/7719344PubMed
37,583,099Functions of fibroblast growth factors and their receptors.Curr Biol1995https://conductscience.org/library/papers/7583099PubMed
48,585,128Fibroblast-growth-factor receptor mutations in human skeletal disorders.Trends Genet1995https://conductscience.org/library/papers/8585128PubMed
58,663,044Receptor specificity of the fibroblast growth factor family.J Biol Chem1996https://conductscience.org/library/papers/8663044PubMed
68,755,573Constitutive receptor activation by Crouzon syndrome mutations in fibroblast growth factor receptor (FGFR)2 and FGFR2/Neu chimeras.Proc Natl Acad Sci U S A1996https://conductscience.org/library/papers/8755573PubMed
79,427,842The heparan sulfate-fibroblast growth factor family: diversity of structure and function.Prog Nucleic Acid Res Mol Biol1998https://conductscience.org/library/papers/9427842PubMed
89,435,295Fibroblast growth factor receptor 2 (FGFR2)-mediated reciprocal regulation loop between FGF8 and FGF10 is essential for limb induction.Development1998https://conductscience.org/library/papers/9435295PubMed
99,560,232Targeted disruption of fibroblast growth factor (FGF) receptor 2 suggests a role for FGF signaling in pregastrulation mammalian development.Proc Natl Acad Sci U S A1998https://conductscience.org/library/papers/9560232PubMed
109,582,367Characterization of recombinant human fibroblast growth factor (FGF)-10 reveals functional similarities with keratinocyte growth factor (FGF-7).J Biol Chem1998https://conductscience.org/library/papers/9582367PubMed

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.

PMIDTitleJournalYearIn PapersSource
36,806,206Mendelian inheritance revisited: dominance and recessiveness in medical genetics.Nat Rev Genet2023https://conductscience.org/library/papers/36806206PubMed
34,007,2772b or Not 2b: How Opposing FGF Receptor Splice Variants Are Blocking Progress in Precision Oncology.J Oncol2021https://conductscience.org/library/papers/34007277PubMed
30,234,486Quantification of gene expression patterns to reveal the origins of abnormal morphogenesis.Elife2018https://conductscience.org/library/papers/30234486PubMed
27,859,991Signaling networks in joint development.Dev Dyn2017https://conductscience.org/library/papers/27859991PubMed
26,589,935From Bench to Bedside and Back: Improving Diagnosis and Treatment of Craniofacial Malformations Utilizing Animal Models.Curr Top Dev Biol2015https://conductscience.org/library/papers/26589935PubMed
26,340,332A Genetic-Pathophysiological Framework for Craniosynostosis.Am J Hum Genet2015https://conductscience.org/library/papers/26340332PubMed
26,220,993Fibroblast growth factor signaling in skeletal development and disease.Genes Dev2015https://conductscience.org/library/papers/26220993PubMed
25,772,309The Fibroblast Growth Factor signaling pathway.Wiley Interdiscip Rev Dev Biol2015https://conductscience.org/library/papers/25772309PubMed
24,489,893A Ser252Trp mutation in fibroblast growth factor receptor 2 (FGFR2) mimicking human Apert syndrome reveals an essential role for FGF signaling in the regulation of endochondral bone formation.PLoS One2014https://conductscience.org/library/papers/24489893PubMed
23,732,477Molecular mechanisms of fibroblast growth factor signaling in physiology and pathology.Cold Spring Harb Perspect Biol2013https://conductscience.org/library/papers/23732477PubMed

1 to 10 of 19

See all 19 cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
FGFR22,263PubTator's text mininghttps://conductscience.org/library/genes/2263

Source NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/11274381

GET https://conductscience.org/api/papers/v1/11274381/references?page=2